Changes

Jump to: navigation, search

Adalimumab

301 bytes added, 14:33, 4 February 2019
no edit summary
|1–30 µg/mL
|1:200<br />1:1500<br />1:2000
|Total: CV <15%<br /> Inter-assay: CV <15.4%
|2 hours 10 min.
|-
|0.5-12 µg/mL<br />2.0- 48 µg/mL
|1:100<br />1:400
|Intra-assay: CV <10.1%<br />Inter-assay: CV<14.2%
|1 hour 40 min.
|-
|0.3 - 16 µg/mL
|1:201
|Intra-assay: CV <13.3%<br />Inter-assay: CV<9.7%
|2 hours
|-
|R-Biopharm AG
|GN3043
|RIDA®QUICK ADM Monitoring
|20 μL
|0.5 - 25 μg/ml
|1:441
|Intra-assay: CV < 16.8%<br />Inter-assay: CV< 16.6%
|15 min.
|-
|Bühlmann
|LF-TLAD25
|Quantum Blue® Adalimumab
|10 μL
|1.3 - 35 μg/mL
|1:190
|Intra-assay: CV < 28.6%<br />Inter-assay: CV < 12.6%
|15 min
 
|}<div style="margin-bottom:1em"><sub>''Table 2: Selection of currently available systems for measuring adalimumab.''</sub></div>

Navigation menu